Valuation: Compumedics Limited

Market Cap 4.69Cr 3.13Cr 2.86Cr 2.64Cr 2.39Cr 4.49Cr 292.7Cr 32Cr 13Cr 158.16Cr 12Cr 12Cr 501.02Cr P/E 2027 *
11.2x
P/E 2028 * 7.34x
Enterprise Value 4.69Cr 3.13Cr 2.86Cr 2.64Cr 2.39Cr 4.49Cr 292.7Cr 32Cr 13Cr 158.16Cr 12Cr 12Cr 501.02Cr EV / Sales 2027 *
0.62x
EV / Sales 2028 * 0.52x
Free-Float
36.04%
Yield 2027 *
-
Yield 2028 * -
1 week-2.08%
Current month-2.08%
1 month-2.08%
3 months+2.17%
6 months-16.07%
Current year-29.85%
1 week 0.22
Extreme 0.225
0.24
1 month 0.22
Extreme 0.22
0.25
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.16
Extreme 0.155
0.45
5 years 0.14
Extreme 0.135
0.45
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO - 01/11/2026
Director of Finance/CFO 61 11/11/2009
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.08%-33.80%+20.51% 3.13Cr
-1.44%-2.91%+18.70%+44.95% 26TCr
-1.72%-3.76%+0.93%+6.26% 16TCr
-0.37%-8.34%-26.37%+30.60% 14TCr
-1.01%-3.60%-55.75%-21.51% 6.23TCr
-0.82%-3.72%+22.68%+53.54% 5.97TCr
-2.16%-2.46%+3.83%-14.26% 5.35TCr
-2.40%-1.10%+18.60%+50.94% 4.94TCr
-2.57%-3.05%+17.85%+71.01% 4.49TCr
+1.47%-11.61%-1.47%+49.14% 4.26TCr
Average -1.06%-3.18%-3.48%+29.12% 9TCr
Weighted average by Cap. -1.24%-3.60%+1.08%+29.56%

Financials

2027 *2028 *
Net sales 7.56Cr 5.05Cr 4.6Cr 4.26Cr 3.85Cr 7.22Cr 471.37Cr 51Cr 20Cr 254.71Cr 19Cr 19Cr 806.85Cr 9.1Cr 6.08Cr 5.54Cr 5.12Cr 4.63Cr 8.69Cr 567.39Cr 62Cr 25Cr 306.6Cr 23Cr 22Cr 971.21Cr
Net income 60L 40.06L 36.5L 33.78L 30.56L 57.33L 37Cr 4.08Cr 1.62Cr 20Cr 1.5Cr 1.47Cr 64Cr 92L 61.42L 55.96L 51.8L 46.86L 87.9L 57Cr 6.26Cr 2.48Cr 31Cr 2.3Cr 2.26Cr 98Cr
Net Debt - -
Projected Income Statement - Annual - Compumedics Limited
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
20/26/20 A$0.2350 0.00% 69,144
19/26/19 A$0.2350 -2.08% 74,147
17/26/17 A$0.2400 +2.13% 24,126
16/26/16 A$0.2350 -4.08% 19,300
13/26/13 A$0.2450 +2.08% 4,081
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Compumedics Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2350AUD
Average target price
0.6500AUD
Spread / Average Target
+176.60%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Compumedics Limited